Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

PDS Biotechnology Corporation PDSB

Full chart Compare
Set alert

Price alert · PDSB

All alert types
1.24 USD -0.06 (-4.62%)

Nov 5, 2026, 9:48 AM EST

1.23 Day range 1.29
0.195 52-week range 1.79
YTD
+61.04%
1 year
+37.02%

Financial health

Altman Z-Score

-44.53 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.0×
FY 2016: -9.3×FY 2017: -5.6×FY 2018: -0.2×FY 2019: -1.8×FY 2020: -2.4×FY 2021: -12.3×FY 2022: -9.2×FY 2023: -3.6×FY 2024: -1.6×FY 2025: -1.0×
FY 2016 5y median -3.6× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.9×
FY 2016: 4.0×FY 2017: 4.6×FY 2018: 0.0×FY 2019: 1.1×FY 2020: 1.3×FY 2021: 3.3×FY 2022: 8.6×FY 2023: 5.9×FY 2024: 3.1×FY 2025: 3.9×
FY 2016 5y median 3.9× FY 2025
P/FCF -1.3×
FY 2016: -11.0×FY 2017: -7.0×FY 2018: -0.0×FY 2019: -0.7×FY 2020: -2.7×FY 2021: -16.6×FY 2022: -14.7×FY 2023: -4.6×FY 2024: -1.7×FY 2025: -1.3×
FY 2016 5y median -4.6× FY 2025
EV/EBITDA -0.9×
FY 2016: -6.8×FY 2017: -4.3×FY 2018: 9.4×FY 2019: -0.1×FY 2020: -0.5×FY 2021: -6.7×FY 2022: -8.0×FY 2023: -3.0×FY 2024: -3.1×FY 2025: -0.9×
FY 2016 5y median -3.1× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -77.7%
FY 2016: -9.1%FY 2017: -14.4%FY 2018: -3094.7%FY 2019: -140.1%FY 2020: -36.7%FY 2021: -6.0%FY 2022: -6.8%FY 2023: -21.9%FY 2024: -59.0%FY 2025: -77.7%
FY 2016 5y median -21.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -372.9%
FY 2016: -43.5%FY 2017: -81.5%FY 2018: -137.0%FY 2019: -59.8%FY 2020: -54.7%FY 2021: -26.8%FY 2022: -92.8%FY 2023: -164.3%FY 2024: -197.9%FY 2025: -372.9%
FY 2016 5y median -164.3% FY 2025
ROIC -116.5%
FY 2016: -37.9%FY 2017: -59.7%FY 2018: -39.7%FY 2019: -125.7%FY 2020: -53.7%FY 2021: -26.6%FY 2022: -60.0%FY 2023: -83.4%FY 2024: -86.9%FY 2025: -116.5%
FY 2016 5y median -83.4% FY 2025
ROA -113.1%
FY 2016: -35.0%FY 2017: -54.9%FY 2018: -112.8%FY 2019: -48.3%FY 2020: -48.1%FY 2021: -25.2%FY 2022: -53.1%FY 2023: -72.3%FY 2024: -82.9%FY 2025: -113.1%
FY 2016 5y median -72.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 13.2%
FY 2016: -49.1%FY 2017: -31.5%FY 2018: 17.1%FY 2019: 64.0%FY 2020: 3.9%FY 2021: -43.9%FY 2022: -94.4%FY 2023: -3.3%FY 2024: 15.6%FY 2025: 13.2%
FY 2016 FY 2025
EPS (diluted) 28.2%
FY 2016: -34.4%FY 2017: -24.4%FY 2018: 69.4%FY 2019: 86.0%FY 2020: 38.2%FY 2021: 25.8%FY 2022: -116.7%FY 2023: 2.8%FY 2024: 25.9%FY 2025: 28.2%
FY 2016 FY 2025
Free Cash Flow 20.8%
FY 2016: -42.6%FY 2017: -24.4%FY 2018: 18.9%FY 2019: 45.5%FY 2020: 27.2%FY 2021: 5.0%FY 2022: -105.9%FY 2023: -30.8%FY 2024: -4.2%FY 2025: 20.8%
FY 2016 FY 2025

Financial Health

Current Ratio 3.0×
FY 2016: 16.1×FY 2017: 6.9×FY 2018: 5.6×FY 2019: 5.2×FY 2020: 9.3×FY 2021: 17.8×FY 2022: 7.8×FY 2023: 4.3×FY 2024: 2.6×FY 2025: 3.0×
FY 2016 5y median 4.3× FY 2025
Quick Ratio 3.0×
FY 2016: 16.1×FY 2017: 6.9×FY 2018: 5.6×FY 2019: 5.2×FY 2020: 9.3×FY 2021: 17.8×FY 2022: 7.8×FY 2023: 4.3×FY 2024: 2.6×FY 2025: 3.0×
FY 2016 5y median 4.3× FY 2025
Debt / Equity 1.8×
FY 2016: 0.2×FY 2017: 0.3×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.5×FY 2023: 0.9×FY 2024: 1.1×FY 2025: 1.8×
FY 2016 5y median 0.9× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 2.3×FY 2017: 1.3×FY 2018: 9.7×FY 2019: 1.7×FY 2020: 1.9×FY 2021: 3.0×FY 2022: 1.2×FY 2023: 0.8×FY 2024: 1.6×FY 2025: 0.3×
FY 2016 5y median 1.2× FY 2025
Interest Coverage -5.9×
FY 2016: -32.8×FY 2017: -23.8×FY 2018: -30.2×FY 2019: -462×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -31.6×FY 2023: -10.2×FY 2024: -7.8×FY 2025: -5.9×
FY 2016 5y median -7.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31